These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22515098)

  • 1. Synthesis, characterization and preliminary in vitro evaluation of PTH 1-34 loaded chitosan nanoparticles for osteoporosis.
    Narayanan D; Anitha A; Jayakumar R; Nair SV; Chennazhi KP
    J Biomed Nanotechnol; 2012 Feb; 8(1):98-106. PubMed ID: 22515098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTH 1-34 loaded thiolated chitosan nanoparticles for osteoporosis: oral bioavailability and anabolic effect on primary osteoblast cells.
    Narayanan D; Anitha A; Jayakumar R; Chennazhi KP
    J Biomed Nanotechnol; 2014 Jan; 10(1):166-78. PubMed ID: 24724508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of osteoporosis therapeutic peptide PTH 1-34 loaded pegylated chitosan nanoparticles.
    Narayanan D; Anitha A; Jayakumar R; Chennazhi KP
    Mol Pharm; 2013 Nov; 10(11):4159-67. PubMed ID: 24006937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Parathyroid Hormone-Loaded PLGA Nanoparticles in Porous Scaffolds for Bone Regeneration.
    Gentile P; Nandagiri VK; Pabari R; Daly J; Tonda-Turo C; Ciardelli G; Ramtoola Z
    Int J Mol Sci; 2015 Aug; 16(9):20492-510. PubMed ID: 26343649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-flourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer.
    Anitha A; Chennazhi KP; Nair SV; Jayakumar R
    J Biomed Nanotechnol; 2012 Feb; 8(1):29-42. PubMed ID: 22515092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico design of AVP (4-5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles.
    Kecel-Gunduz S; Budama-Kilinc Y; Cakir-Koc R; Zorlu T; Bicak B; Kokcu Y; E Ozel A; Akyuz S
    Daru; 2020 Jun; 28(1):139-157. PubMed ID: 31942695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico Analysis of Sulpiride, Synthesis, Characterization and In vitro Studies of its Nanoparticle for the Treatment of Schizophrenia.
    Kecel-Gunduz S; Budama-Kilinc Y; Cakir-Koc R; Zorlu T; Bicak B; Kokcu Y; Kaya Z; Ozel AE; Akyuz S
    Curr Comput Aided Drug Des; 2020; 16(2):104-121. PubMed ID: 31244443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
    Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
    Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and carboplatin loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies.
    Khan MA; Zafaryab M; Mehdi SH; Quadri J; Rizvi MM
    Int J Biol Macromol; 2017 Apr; 97():115-122. PubMed ID: 28082219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
    Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and toxicological evaluation of a chitosan-L-leucine conjugate for pulmonary drug delivery applications.
    Muhsin MD; George G; Beagley K; Ferro V; Armitage C; Islam N
    Biomacromolecules; 2014 Oct; 15(10):3596-607. PubMed ID: 25191851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of micrometric powders of parathyroid hormone (PTH1-34)-loaded chitosan oligosaccharide by supercritical fluid assisted atomization.
    Hong DX; Yun YL; Guan YX; Yao SJ
    Int J Pharm; 2018 Jul; 545(1-2):389-394. PubMed ID: 29751142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Delivery of Teriparatide Using a Nanoemulsion System: Design, in Vitro and in Vivo Evaluation.
    Altaani BM; Almaaytah AM; Dadou S; Alkhamis K; Daradka MH; Hananeh W
    Pharm Res; 2020 Apr; 37(4):80. PubMed ID: 32253527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of a Stable and Sustained-Release Formulation of Recombinant Human Parathyroid Hormone (rhPTH) with Chitosan and Silk Fibroin Microparticles.
    Lv BH; Tan W; Zhu CC; Shang X; Zhang L
    Med Sci Monit; 2018 Oct; 24():7532-7540. PubMed ID: 30345994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
    Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
    J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
    Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
    Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
    Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
    Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
    Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.